Exploration of the Binding Modes of Toll-Like Receptor 4 Competitive Inhibitors: A Combined Ligand-Based and Target-Based Approach

被引:2
|
作者
Dang, Wen [1 ]
Meng, Churen [1 ]
Wang, Jian [2 ]
Zhou, Di [2 ]
Chen, Gang [2 ]
Li, Ning [2 ]
机构
[1] Shenyang Pharmaceut Univ, Sch Tradit Chinese Mat Med, Key Lab TCM Mat Basis Study & Innovat Drug Dev She, Shenyang 110016, Peoples R China
[2] Shenyang Pharmaceut Univ, Sch Pharmaceut Engn, Key Lab Struct, Based Drug Design & Discovery Minist Educ, 103 Wenhua Rd, Shenyang 110016, Peoples R China
基金
中国国家自然科学基金;
关键词
TLR4; MD-2; pharmacophores; competitive inhibitors; blind docking; MOLECULAR-DYNAMICS; INNATE IMMUNITY; TLR4; DOCKING;
D O I
10.1002/cmdc.202200690
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The interactions of Toll-like receptor 4 (TLR4) with competitive inhibitors were investigated by a combined ligand-based and target-based approach. Firstly, the ligand-based pharmacophore model of the reported TLR4 inhibitors was constructed by utilizing the common feature method, which included three hydrophobic groups and a hydrogen bond receptor. The Schrodinger software suite glide module was used to dock inhibitors with proteins and verify the importance of these four interaction points from the target level. Then, molecular dynamics, alanine scanning mutagenesis, and binding free energy calculation were used to identify the key amino acids in the binding mode. In addition, blind docking proved that the TLR4 inhibitor does not bind to TLR4 itself like other TLR family proteins. Based on this, we also screened a class of sesquiterpene coumarins which possibly have TLR4 inhibitory activity and will conduct a detailed study later. Together, this study revealed the interactions between TLR4 protein and its competitive inhibitors, which shed light on better access for developing its novel inhibitors.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Discovery of Novel Adenosine Receptor Antagonists through a Combined Structure- and Ligand-Based Approach Followed by Molecular Dynamics Investigation of Ligand Binding Mode
    Lagarias, Panagiotis
    Vrontaki, Eleni
    Lambrinidis, George
    Stamatis, Dimitrios
    Convertino, Marino
    Ortore, Gabriella
    Mavromoustakos, Thomas
    Klotz, Karl-Norbert
    Kolocouris, Antonios
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2018, 58 (04) : 794 - 815
  • [32] A Ligand-Based Approach to the Discovery of Lead-Like Potassium Channel KV1.3 Inhibitors
    Pereira, Gilberto
    Szwarc, Beatriz
    Mondragao, Miguel A.
    Lima, Pedro A.
    Pereira, Florbela
    CHEMISTRYSELECT, 2018, 3 (05): : 1352 - 1364
  • [33] Novel aldosterone synthase inhibitors with extended carbocyclic skeleton by a combined ligand-based and structure-based drug design approach
    Lucas, Simon
    Heim, Ralf
    Negri, Matthias
    Antes, Iris
    Ries, Christina
    Schewe, Katarzyna E.
    Bisi, Alessandra
    Gobbi, Silvia
    Hartmann, Rolf W.
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (19) : 6138 - 6149
  • [34] Identification of Toll-like receptor signaling inhibitors based on selective activation of hierarchically acting signaling proteins
    Ippagunta, Sirish K.
    Pollock, Julie A.
    Sharma, Naina
    Lin, Wenwei
    Chen, Taosheng
    Tawaratsumida, Kazuki
    High, Anthony A.
    Min, Jaeki
    Chen, Yizhe
    Guy, R. Kiplin
    Redecke, Vanessa
    Katzenellenbogen, John A.
    Hacker, Hans
    SCIENCE SIGNALING, 2018, 11 (543)
  • [35] Validation of potential inhibitors for SrtA against Bacillus anthracis by combined approach of ligand-based and molecular dynamics simulation
    Selvaraj, Chandrabose
    Singh, Sanjeev Kumar
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2014, 32 (08): : 1333 - 1349
  • [36] Toll-like receptor 4 agonist-based nanoparticles orchestrate protection against sepsis
    Yongxiang Zhao
    Xinjing Lv
    Jie Huang
    Huiting Zhou
    Hairong Wang
    Jian Wang
    He Zhao
    Journal of Materials Science, 2022, 57 : 2089 - 2099
  • [37] Toll-like receptor 4 agonist-based nanoparticles orchestrate protection against sepsis
    Zhao, Yongxiang
    Lv, Xinjing
    Huang, Jie
    Zhou, Huiting
    Wang, Hairong
    Wang, Jian
    Zhao, He
    JOURNAL OF MATERIALS SCIENCE, 2022, 57 (03) : 2089 - 2099
  • [38] Development of Potent Inhibitors of Receptor Tyrosine Kinases by Ligand-Based Drug Design and Target-Biased Phenotypic Screening
    Myers, Samuel H.
    Temps, Carolin
    Houston, Douglas R.
    Brunton, Valerie G.
    Unciti-Broceta, Asier
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (05) : 2104 - 2110
  • [39] Protective Effect of Ginsenosides Rg1 and Re on Lipopolysaccharide-Induced Sepsis by Competitive Binding to Toll-Like Receptor 4
    Su, Fei
    Xue, Yin
    Wang, Yuemin
    Zhang, Lili
    Chen, Wangxue
    Hu, Songhua
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (09) : 5654 - 5663
  • [40] Ligand-based modeling of semicarbazones and thiosemicarbazones derivatives as Cathepsin B, H, and L inhibitors: A multi-target approach
    Pandey, Vandana
    Sharma, Kavita
    Raghav, Neera
    JOURNAL OF MOLECULAR STRUCTURE, 2022, 1257